Quick links

Showcase Innovations

KwickScreen »

ID5: Distribute the Product

KwickScreen is the world's most portable retractable screen or room divider. The screens are 2m high, can be pulled out to anything up to 3.5m wide, and retract back into a compact vertical compartment.

View project
Owner:
Peter Taylor

Tracheal transplant »

ID5: Distribute the Product

Until now, transplants of the airways have not been performed because they would require the use of huge doses of immunosuppressive drugs. However, this pioneering procedure used tissue-engineering techniques to develop a biologically-treated organ with which surgeons were able to replace a damaged bronchus without the need for immunosuppressive medication.

View project
Owner:
Robert Chesters

Big White Wall »

ID5: Distribute the Product

BWW is part of the vanguard for transforming mental health services in the UK. It offers the first online pathway for mental health and wellbeing which places people at the centre of their own care. It also uniquely re-imagines the role of clinician from ‘expert’ to ‘coach’. Its widespread adoption is enabling people to access well-governed and safe therapeutic services through self-referral from the comfort of their own homes.

View project
Owner:
Robert Chesters
Tags:
Mental health

NHS BLOOD DONOR CHAIR »

ID5: Distribute the Product

Renfrew Group International (RGi) worked in close partnership with NHS Blood and Transplant (NHSBT) in the successful, user-centered design and implementation of the new Phlebotomy (Blood Donor) chair and trolley system to enhance the donation experience and improve the whole process for patients, collection and support staff. This partnership approach between RGi and NHSBT provided a real opportunity for innovation in the NHS procurement processes and a breakthrough in competitive tendering, whilst delivering excellence in engineering, value, quality and reliability.

View project
Owner:
Andrew Slaney

Zilico Non Invasive Cancer Diagnostic »

ID5: Distribute the Product

A portable diagnostic device able to differentiate between healthy, pre-malignant and abnormal cells has been developed to provide superior performance over existing diagnostic procedures in the detection and treatment of cervical cancer. Based on electrical impedance spectroscopy, the device has undergone extensive testing and evaluation on nearly 1,000 patients in a number of clinical trials, all subject to peer reviewed publications and presented at key scientific meetings. Results from the latest multi-centre trial are forming part of the submission for regulatory approval with a view to the first product being launched in Q1 of 2013.

View project
Owner:
Robert Chesters

ePAQ- PO »

ID5: Distribute the Product

ePAQ has been designed primarily as a clinical tool, to facilitate communication between patients & clinicians. It has been evaluated in a number of studies in terms of its validity, reliability & impact on patient care. Its origins lie in instruments designed for use as Patient Reported Outcome Measures (PROMs) though most importantly the system offers a user-friendly and meaningful measure of outcome, which may be applicable in clinical practice, service evaluation, audit & research. It is a key element in supporting devolved care (including nurse-led clinics) as well as ‘Virtual Clinics’

View project
Owner:
Peter Taylor

PainKwell »

ID5: Distribute the Product

A low cost ambulatory acute pain management system that has proven to relieve postoperative pain for patients following several types of surgery, especially hip and knee replacement. Using patent pending components it is a proven, safer means of avoiding wound infection, faster surgical application and a key factor in patient enhanced recovery programmes whilst reducing the use of opiates.

View project
Owner:
Peter Taylor

RehabAngel »

ID5: Distribute the Product

The RehabAngel is a unique variable incline device that provides control and safety for patients requiring lower limb exercises.

View project
Owner:
Robert Chesters
Tags:
Rehabilitation , Physiotherapy

GraftBolt »

ID5: Distribute the Product

A new ACL tibial fixation device (GraftBolt®) was developed by an NHS surgeon at the University Hospital of South Manchester NHS Foundation Trust in collaboration with University of Manchester mechanical engineers. TrusTECH (NHS Innovation Hub for the North West) and the University funded the initial development work, testing and patent filing. Arthrex was granted a licence to manufacture and sell the device. GraftBolt® was placed on the market by Arthrex in 2010.

View project
Owner:
Robert Chesters